The Mediating Role of Insulin Resistance in the Association Between Inflammatory Score and MAFLD: NHANES 2017-2018

Overview

Journal Immun Inflamm Dis

Specialties Allergy & Immunology
Infectious Diseases

Date 2024 Oct 4

PMID 39364712

Authors

Yan Chen

Xin Zhao

Affiliations

Soon will be listed here.

Abstract

Background: The association between inflammatory score, insulin resistance (IR), and metabolic-associated fatty liver disease (MAFLD) is inconclusive.

Objective: The objective of this study was to examine the relationship between the inflammatory score and MAFLD and investigate the potential mediating effect of IR (evaluated by triglyceride-glucose index) in this association.

Methods: Calculating inflammatory score was performed based on white blood cells and high-sensitivity C-reactive protein. The association between the inflammatory score and MAFLD was evaluated based on the weighted multifactor logistic regression model. Restricted cubic splines (RCS) were used to visualize the dose-response relationship between the inflammatory score and MAFLD. We also conducted a mediation analysis to assess the extent to which IR mediates this association.

Results: Among the 1090 participants, 563 were ultimately diagnosed with MAFLD. Multivariate logistic regression results indicated a close positive association between inflammatory score and MAFLD (odds ratio = 1.235, 95% confidence interval 1.069-1.427, p = .007). The RCS results indicated a linear dose-response relationship between the inflammatory score and the risk of MAFLD after adjusting for potential confounding factors. Furthermore, the mediation analysis results showed that IR partially mediated the association between the inflammatory score and MAFLD (percent mediation = 33%).

Conclusion: Our research results indicate that the inflammatory score is positively associated with the risk of MAFLD, and IR plays a partial mediating effect in this association.

Citing Articles

The association between triglyceride-glucose index and neutrophil-lymphocyte ratio and all-cause mortality in the general US population: NHANES 2001-2018.

Wang Y, Gu C, Chen B, Qiu B, Yu J Front Endocrinol (Lausanne). 2024; 15:1513543.

PMID: 39720246 PMC: 11666386. DOI: 10.3389/fendo.2024.1513543.

Association Between Serum Uric Acid to Creatinine Ratio and Metabolic-Associated Fatty Liver Disease in Southeast China (TyG-BMI as a Potential Mediator).

Chen B, Peng X Diabetes Metab Syndr Obes. 2024; 17:4711-4720.

PMID: 39678226 PMC: 11638475. DOI: 10.2147/DMSO.S489692.

The mediating role of insulin resistance in the association between inflammatory score and MAFLD: NHANES 2017-2018.

Chen Y, Zhao X Immun Inflamm Dis. 2024; 12(10):e70035.

PMID: 39364712 PMC: 11450453. DOI: 10.1002/iid3.70035.

References

Luci C, Bourinet M, Leclere P, Anty R, Gual P . Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies. Front Endocrinol (Lausanne). 2021; 11:597648. PMC: 7771356. DOI: 10.3389/fendo.2020.597648. View

Duan Y, Luo J, Pan X, Wei J, Xiao X, Li J . Association between inflammatory markers and non-alcoholic fatty liver disease in obese children. Front Public Health. 2022; 10:991393. PMC: 9751435. DOI: 10.3389/fpubh.2022.991393. View

Temelkova-Kurktschiev T, Siegert G, Bergmann S, Henkel E, Koehler C, Jaross W . Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism. 2002; 51(6):743-9. DOI: 10.1053/meta.2002.32804. View

Liu Q, Han M, Li M, Huang X, Feng R, Li W . Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study. Lipids Health Dis. 2023; 22(1):185. PMC: 10613356. DOI: 10.1186/s12944-023-01947-4. View

Chen Y, Xie K, Han Y, Xu Q, Zhao X . An Easy-to-Use Nomogram Based on SII and SIRI to Predict in-Hospital Mortality Risk in Elderly Patients with Acute Myocardial Infarction. J Inflamm Res. 2023; 16:4061-4071. PMC: 10505402. DOI: 10.2147/JIR.S427149. View

Gonzalez-Gil E, Santabarbara J, Ruiz J, Bel-Serrat S, Huybrechts I, Pedrero-Chamizo R . Ideal cardiovascular health and inflammation in European adolescents: The HELENA study. Nutr Metab Cardiovasc Dis. 2017; 27(5):447-455. DOI: 10.1016/j.numecd.2016.12.003. View

Jung C, Lee W, Kim B, Park S, Rhee E, Park C . The risk of metabolic syndrome according to the white blood cell count in apparently healthy Korean adults. Yonsei Med J. 2013; 54(3):615-20. PMC: 3635622. DOI: 10.3349/ymj.2013.54.3.615. View

Sun W, Fang Y, Zhou B, Mao G, Cheng J, Zhang X . The association of systemic inflammatory biomarkers with non-alcoholic fatty liver disease: a large population-based cross-sectional study. Prev Med Rep. 2024; 37:102536. PMC: 10767190. DOI: 10.1016/j.pmedr.2023.102536. View

Rattan P, Penrice D, Ahn J, Ferrer A, Patnaik M, Shah V . Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population. Hepatol Commun. 2021; 6(2):399-410. PMC: 8793996. DOI: 10.1002/hep4.1803. View

10.

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

11.

Gomez Rosso L, Benitez M, Cecilia Fornari M, Berardi V, Lynch S, Schreier L . Alterations in cell adhesion molecules and other biomarkers of cardiovascular disease in patients with metabolic syndrome. Atherosclerosis. 2007; 199(2):415-23. DOI: 10.1016/j.atherosclerosis.2007.11.007. View

12.

Ford E . The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2003; 168(2):351-8. DOI: 10.1016/s0021-9150(03)00134-5. View

13.

Mazidi M, Katsiki N, Mikhailidis D, Banach M . Association of ideal cardiovascular health metrics with serum uric acid, inflammation and atherogenic index of plasma: A population-based survey. Atherosclerosis. 2019; 284:44-49. DOI: 10.1016/j.atherosclerosis.2018.09.016. View

14.

Wong R, Cheung R . Trends in the Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in the United States, 2011-2018. Clin Gastroenterol Hepatol. 2021; 20(3):e610-e613. DOI: 10.1016/j.cgh.2021.01.030. View

15.

Greenberg A, McDaniel M . Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest. 2002; 32 Suppl 3:24-34. DOI: 10.1046/j.1365-2362.32.s3.4.x. View

16.

Mazidi M, Toth P, Banach M . C-reactive Protein Is Associated With Prevalence of the Metabolic Syndrome, Hypertension, and Diabetes Mellitus in US Adults. Angiology. 2017; 69(5):438-442. DOI: 10.1177/0003319717729288. View

17.

Lohsoonthorn V, Dhanamun B, Williams M . Prevalence of metabolic syndrome and its relationship to white blood cell count in a population of Thai men and women receiving routine health examinations. Am J Hypertens. 2006; 19(4):339-45. DOI: 10.1016/j.amjhyper.2005.10.008. View

18.

Haffner S . The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006; 97(2A):3A-11A. DOI: 10.1016/j.amjcard.2005.11.010. View

19.

Simental-Mendia L, Rodriguez-Moran M, Guerrero-Romero F . The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008; 6(4):299-304. DOI: 10.1089/met.2008.0034. View

20.

Bi Y, Gao Y, Xie Y, Zhou M, Liu Z, Tian S . White blood cells and type 2 diabetes: A Mendelian randomization study. PLoS One. 2024; 19(3):e0296701. PMC: 10906821. DOI: 10.1371/journal.pone.0296701. View